http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8806462471496d61f091bf079e6e90ca
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Frangioni V. Frangioni |
| name | John V Frangioni John V. Frangioni |
| given-name | John John V. John V |
| organization-name | 1 Molecular Medicine Unit, Beth Israel Hospital, Boston, MA 02215, USA Curadel, LLC, 11 Erie Drive, Natick, Massachusetts 01760, United States Department of Chemistry, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, Division of Hematology/Oncology and Department of Radiology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, Massachusetts 02215, and Department of Molecular Science and Technology, Ajou University, 5 Wonchun-Dong Yeongtong-Gu Suwon, Korea 443-749 From the Division of Hematology/Oncology, Department of Medicine, and Department of Radiology, Beth Israel Deaconess Medical Center, Boston, MA, and Molecular Imaging and Diagnostics Advanced Technology Program, Biosciences Organization, General Electric Global Research, Niskayuna, NY. Department of Medicine Beth Israel Deaconess Medical Center Boston MA; Department of Radiology Beth Israel Deaconess Medical Center Boston MA; Curadel, LLC Worcester MA From the Department of Radiology (A.Z., J.V.F.) and Division of Hematology/Oncology (A.M.D., J.V.F.), Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Mass; Department of Molecular and Human Genetics (M.M., G.K.), Baylor College of Medicine, Houston, Tex; GE Healthcare Biosciences (T.G.M.), Boston, Mass. From the Department of Radiology, Harvard Medical School, and the Center for Molecular Imaging, Beth Israel Deaconess Medical Center, Boston, MA Beth Israel Deaconess Medical Center, Boston, MA The Curadel Companies 11 Erie Drive Natick MA 01760 USA Department of Medicine Beth Israel Deaconess Medical Center Boston USA; Department of Radiology Beth Israel Deaconess Medical Center Boston USA 12Curadel, LLC, Marlborough, Massachusetts. Molecular Medicine Unit, Beth Israel Hospital, Boston, MA 02215, USA From the Division of Hematology/Oncology, Department of Medicine, and Department of Radiology, Beth Israel Deaconess Medical Center, Boston, MA; Division of Cancer Diagnostics and Therapeutics, Hokkaido University Graduate School of Medicine, Sapporo, Japan; and Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands Division of Hematology/Oncology, Department of Medicine, and Department of Radiology, Beth Israel Deaconess Medical Center, SL-B05, 330 Brookline Avenue, Boston, Massachusetts 02215, and Justus-Liebig-Universität Giessen, Institut für Organische Chemie, Heinrich-Buff-Ring 58, 35392 Giessen, Germany Beth Israel Deaconess Medical Center Division of Hematology/Oncology, Department of Medicine Beth Israel Deaconess Medical Center Boston MA 02215 USA; Department of Radiology Beth Israel Deaconess Medical Center Boston MA 02215 USA Beth Israel Deaconess Medical Center, Boston, MA, USA Division of Hematology/Oncology, Department of Medicine and, Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215 Beth Israel Deaconess CenterHarvard Medical SchoolBostonMassachusetts From the Division of Hematology/Oncology, Department of Radiology, and Molecular Imaging Center, Beth Israel Deaconess Medical Center (J.V.F.); the Cardiology Laboratory of Integrative Physiology & Imaging, Cardiovascular Research Center, Massachusetts General Hospital (R.J.H.); and Harvard Medical School (J.V.F., R.J.H.), Boston, Mass. Address reprint requests to: John V. Frangioni, MD, PhD, Associate Professor of Medicine and Associate Professor of Radiology Harvard Medical School, Boston, MA; Co-Director, Center for Molecular Imaging, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Room SL-B05, Boston, MA 02215; Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215 Universität Hamburg, Institut für Organische Chemie, Martin-Luther-King-Platz 6, 20146 Hamburg, Germany, and Harvard Medical School, Beth Israel Deaconess Medical Center, SL-B05, 330 Brookline Avenue, Boston, Massachusetts 02215 Division of Hematology/Oncology, Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School Robotic Chemistry Group, Center for Molecular Imaging, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, United States Contribution from the Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, and Department of Molecular Science and Technology, Ajou University, Suwan 443-749, Korea Department of Medicine Beth Israel Deaconess Medical Center, Harvard Medical School Boston MA; Division of Hematology and Oncology Beth Israel Deaconess Medical Center, Harvard Medical School Boston MA; Department of Radiology Beth Israel Deaconess Medical Center, Harvard Medical School Boston MA; Curadel, LLC Worcester MA Department of Radiology, Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts From the Division of Hematology/Oncology, Department of Medicine, and Department of Radiology, Beth Israel Deaconess Medical Center, Boston, MA. Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts From the Division of Hematology/Oncology and Department of Radiology, Beth Israel Deaconess Medical Center, Boston, MA; Functional Imaging Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Japan; School of Radiological Science, Faculty of Health Sciences, Tokyo Metropolitan University, Tokyo, Japan; inviCRO, LLC, Boston, MA; Department of Pharmaceutical Sciences, Northeastern University, Boston, MA; and Bioscan, Inc., Washington, DC. From Curadel, LLC, Worcester, MA, the Departments of Medicine, Pathology, and Radiology, Beth Israel Deaconess Medical Center, Boston, MA, and Siemens Corporation, Corporate Research, Princeton, NJ From the Division of Hemostasis and Thrombosis (R.F., G.J.G.), the Division of Hematology/Oncology (E.T., A.M.D.G., R.G.L., J.V.F.), and the Department of Radiology (J.V.F.), Beth Israel Deaconess Medical Center, and the Cardiovascular Research Center (K.H., R.J.H.), Massachusetts General Hospital, Boston, Mass. Department of Radiology; Beth Israel Deaconess Medical Center; Boston Massachusetts; Division of Hematology/Oncology, Department of Medicine; Beth Israel Deaconess Medical Center; Boston Massachusetts Division of Hematology/Oncology; Department of Medicine; Beth Israel Deaconess Medical Center; Boston; USA Division of Hematology/Oncology, Department of Medicine, and Department of Radiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, and Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 Curadel, LLC, Worcester, MA, USA Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Department of Radiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts From the Division of Hematology/Oncology, Department of Medicine, and Department of Radiology, Beth Israel Deaconess Medical Center, Boston, MA, and CEA-LETI-MINATEC, Grenoble, France Curadel, LLC, Marlborough, MA, U.S.A; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, U.S.A; Department of Radiology, Beth Israel Deaconess Medical Center, Boston, MA, U.S.A 4Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MA 02215 Beth Israel Deaconess Medical Ctr. Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MA 02115; and Division of Hematology/Oncology; Department of Medicine; Beth Israel Deaconess Medical Center and Harvard Medical School; Boston, USA; Department of Radiology Robotic Chemistry Group, Center for Molecular Imaging, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, United States; Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, United States; Department of Radiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, United States 5Curadel, LLC, Natick, Massachusetts. Division of Hematology/Oncology, Beth Israel Deaconess Medical Center SL-B05, 330 Brookline Avenue Boston, MA 02215; Department of Radiology, Beth Israel Deaconess Medical Center SL-B05, 330 Brookline Avenue Boston, MA 02215; Molecular Imaging Group, Beth Israel Deaconess Medical Center SL-B05, 330 Brookline Avenue Boston, MA 02215 Department of Medicine Beth Israel Deaconess Medical Center Boston Massachusetts; Department of Radiology Beth Israel Deaconess Medical Center Boston Massachusetts From the Division of Hematology/Oncology, Department of Medicine, and Department of Radiology, Beth Israel Deaconess Medical Center, Boston, MA Division of Hematology/Oncology, Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. Curadel, LLC, 377 Plantation Street, Worcester, Massachusetts 01605, United States From the Division of Hematology/Oncology and Department of Radiology, Beth Israel Deaconess Medical Center, Boston, MA; Molecular Imaging and Diagnostic Advanced Technology Program, GE Global Research, Niskayuna, NY; and Division of Thoracic Surgery, Brigham and Women's Hospital, Boston, MA Institute of Organic Chemistry, Justus-Liebig-Universität Giessen, Heinrich-Buff-Ring 58, 35390 Giessen, Germany, Department of Medicine and Department of Radiology, Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, Massachusetts 02215, and MGI Pharma, 6611 Tributary Street, Baltimore, Maryland 21224 Department of Chemistry, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, Division of Hematology/Oncology and Department of Radiology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, Massachusetts 02215 Authors' Affiliations: Departments of 1Chemical Engineering and 2Biological Engineering, and 3Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge; and Departments of 4Medicine and 5Radiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Authors' Affiliations: Departments of 1Chemical Engineering and 2Biological Engineering, and 3Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge; and Departments of 4Medicine and 5Radiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts |
Incoming Links
Total number of triples: 257.